BioAge Labs
Price & Volume
Stats
See more52W Range | $2.88-$26.62 |
Market Cap | $200.7M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $3.8M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$7.2M |
Diluted EPS | -$6.81 |
News
See moreYahoo Finance • 3 days ago
Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
Yahoo Finance • 7 days ago
BioAge Labs files $250M mixed securities shelf
Yahoo Finance • 8 days ago
BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Yahoo Finance • 11 days ago
Leqembi® approved for IV maintenance treatment in China
About
CEO | Dr. Kristen Fortney Ph.D. |
Address | 1445A South 50th Street, Richmond, CA, United States, 94804 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 62 |
